Interferon- -1b: A Review of its Use in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By McCormack P.L.   Scott L.J.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 521-546

Adis International

Access to resources Recommend Favorite

Novel vaccine show promise for relapsing-remitting MS

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

IFN- treatment cost driver in relapsing-remitting MS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

IFN- treatment cost driver in relapsing-remitting MS

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of a 'Refrigeration-free' Formulation of Interferon Beta-1b – Results of a Double-blind, Multicentre, Comparative Study in Patients with Relapsing–Remitting or Secondary Progressive Multiple Sclerosis

By Baum K    

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 1-12

Field House Publishing

Access to resources Recommend Favorite